(Nasdaq: LEXX & LEXXW) (the Company or Lexaria), a global innovator in drug delivery platforms announces additional positive interim results from a human pilot study (the Study) evaluating DehydraTECHTM technology for the oral delivery of the glucagon-like peptide-1 (GLP-1) drug semaglutide available commercially in the branded product Rybelsus, further to its previously announced findings from this work
Preventive effect of dietary quercetin on disuse muscle atrophy by targeting mitochondria in denervated mice
Some patients benefit from starting B12 supplementation at the same time they begin semaglutide therapy, while others may only need it after 36 months of GLP-1 treatment
We do not claim affiliation with or endorsement by Novo Nordisk
To whom it may concern its still too early to tell if those injections are working
Seth Kipnis , MD, medical director of bariatric and robotic surgery at Hackensack Meridian Jersey Shore University Medical Center, writes that the Wegovy pill may come with a greater frequency of side effects, including more frequent gastrointestinal events such as higher rates of nausea and vomiting